Citations

Mayo Clinic

Showing 10 of 108599 citations.

The health information national trends survey (HINTS): A resource for consumer engagement and health communication research
Hesse, Bradford W. , Greenberg, Alexandra J. , Peterson, Emily , Chou, Wen‐Ying Sylvia

Information Services and Use | June 16, 2017 | Volume: 37 | Issue: 2 | Pages: 205-218

10.3233/isu-170830 Get It

The contemporary healthcare system can help improve health literacy outcomes in two ways: first, by nurturing the skills and motivations needed for patients to be actively engaged in their own health and healthcare decisions; and, second, by creating a prepared and proactive healthcare system that adapts to patients’ capacities and needs in efficacious ways. In 2001, the National Cancer Institute launched the Health Information National Trends Survey (HINTS) as a way for researchers and planners to understand how the public is interacting with a rapidly changing health information environment. Original iterations of the HINTS national probability sampling strategies took place on a biennial basis, but in subsequent years the protocol moved to a yearly administration. This yields a rich resource of cross-sectional, national surveillance data to evaluate for trends across and within vulnerable populations. Sixteen studies are presented from the published literature to illustrate how HINTS data were used to explore constructs of direct interest to health literacy researchers. Suggestions are given for how this ongoing public surveillance mechanism can be used: (a) to provide a sentinel view of how the public is interacting with information in the environment to address their health needs; (b) to generate research questions and hypotheses for further exploration using complementary methodologies; and (c) to explore the diffusion of new health communication channels within and between segments of the national population.
Restoration of Articular Geometry Using Current Graft Options for Large Glenoid Bone Defects in Anterior Shoulder Instability
Willemot, Laurent , Akbari-Shandiz, Mohsen , Zhao, Kristin D. , Verborgt, Olivier , Willemot, Laurent B, Sanchez-Sotelo, Joaquin, Zhao, Kristin, Sánchez‐Sotelo, Joaquín , Trentadue, Taylor P

Arthroscopy | June 16, 2017 | Volume: 33 | Issue: 9 | Pages: 1661-1669

10.1016/j.arthro.2017.04.002 | PMID 28623079 Get It

Purpose The purpose of this cadaveric study was to compare standard and modified coracoid transfer procedures, bicortical and tricortical iliac crest autografts, and tibial plafond and glenoid allografts with respect to glenoid surface curvature restoration. Methods Computed tomography scans of 8 cadaveric shoulders were acquired in 9 conditions: (1) intact, (2) 25% width defect, (3) classic Latarjet, (4) modified congruent‐arc Latarjet, (5) tricortical iliac crest inner table, (6) outer table, (7) bicortical iliac crest, (8) distal tibia, and (9) glenoid allograft. Outcome measures included articular surface area, width, depth, axial and coronal radius of curvature, and subchondral articular step‐off, analyzed in bone and soft‐tissue window. Results Reconstruction of the articular surface area was optimal with the glenoid allograft (99.4%), classic Latarjet (97.4%), and iliac crest bicortical graft (93.2%). Depth was best restored by the congruent‐arc Latarjet (101.0%), tibial (98.9%), and glenoid (95.3%) allografts. Axial curvature was closely matched by the glenoid allograft (97.5%), classic Latarjet (108.7%), and iliac bicortical graft (91.2%). Coronal curvature was most accurately restored by the glenoid allograft (102.6%), the tibial allograft (115.0%), and the classic Latarjet (55.9%). The articular step‐off was smallest using the glenoid allograft. Conclusions Overall, glenoid allografts most accurately restored articular geometry. Alternative grafts provided restoration of some parameters but not others. Classic Latarjet performed well in axial and coronal curvature on average but exhibited large variability. Tibial allograft produced the poorest results in axial curvature, despite excellent coronal curvature reconstruction. The congruent‐arc Latarjet did not restore the axial curvature accurately and overcorrected coronal curvature. Graft geometry must be weighed against availability, morbidity, and the role of additional stabilizers. Clinical Relevance Accurate graft morphology may help prevent postoperative osteoarthritis. Grafts differ significantly regarding geometric parameters. The findings of this study will help surgeons select the most appropriate graft for glenoid reconstruction.
A consensus review on malignancy‐associated hemophagocytic lymphohistiocytosis in adults
Daver, Naval , McClain, Kenneth L. , Allen, Carl E. , Otrock, Zaher K. , Rojas‐Hernandez, Cristhiam M. , Blechacz, Boris, Wang, Sa , Minkov, Milen , Jordan, Michael B. , Rosée, Paul La , Kantarjian, Hagop M. , Parikh, Sameer A. , Daver, Naval , McClain, Kenneth L , Allen, Carl E , Kantarjian, Hagop

Cancer | June 16, 2017 | Volume: 123 | Issue: 17 | Pages: 3229-3240

10.1002/cncr.30826 | PMID 28621800 Get It

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe immune activation and dysregulation resulting in extreme and often life‐threatening inflammation. HLH has been well recognized in pediatric populations, and most current diagnostic and therapeutic guidelines are based on pediatric HLH. Recently there has been recognition of HLH in adults, especially secondary to immune deregulation by an underlying rheumatologic, infectious, or malignant condition. This review is focused on malignancy‐associated HLH (M‐HLH), in which possible mechanisms of pathogenesis include severe inflammation, persistent antigen stimulation by the tumor cells, and loss of immune homeostasis because of chemotherapy, hematopoietic stem cell transplantation, or infection. Previously considered rare, M‐HLH may occur in up to 1% of patients with hematologic malignancies. M‐HLH is often missed or diagnosed late in most published studies, and it has been associated with a poor median survival of less than 2 months. Identification of the clinical and laboratory features specific to M‐HLH in adults may allow early detection, consultation with HLH experts, and intervention. Improved management of adult M‐HLH with optimal combinations of T‐lympholytic and immunosuppressive agents and the incorporation of novel agents based on the pediatric experience hopefully will improve outcomes in adults with M‐HLH. Cancer 2017;123:3229‐40. © 2017 American Cancer Society.
Erratum: “Estimating organ doses from tube current modulated CT examinations using a generalized linear model” [Med. Phys. Vol 44 (4), 1500-1513 (2017)]
Bostani, Maryam, McMillan, Kyle, Lu, Peiyun, Cody, Dianna D. , Arbique, Gary, Greenberg, S. Bruce , DeMarco, John J., Cagnon, Chris H., Kim, Grace Hyun J. , McNitt‐Gray, Michael F.

Medical Physics | June 16, 2017 | Volume: 44 | Issue: 7 | Pages: 3883-3883

10.1002/mp.12324 | PMID 28685929 Get It

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Springer, Bryan D. , Dasa, Vinod , George, Michael , Gewurz‐Singer, Ora, Giles, Jon T. , Johnson, Beverly , Mandl, Lisa A. , Mont, Michael A. , Sculco, Peter K. , Sporer, Scott M. , Stryker, Louis S., Turgunbaev, Marat, Brause, Barry D. , Gililland, Jeremy M. , Goodman, Mark A. , Hurley-Rosenblatt, Arlene, Kirou, Kyriakos A. , Losina, Elena , MacKenzie, Ronald, Russell, Linda , Sah, Alexander P. , Miller, Amy S., Singh, Jasvinder A. , Yates, Adolph J. , Losina, Elena , George, Michael , Losina, Elena , Singh, Jasvinder A , Goodman, Susan M. , Guyatt, Gordon , Abdel, Matthew P. , Lee, Steve C. , Chen, Antonia F. , Michaud, Kaleb D. , Mikuls, Ted R. , Losina, Elena , Giles, Jon T , Kirou, Kyriakos A

Arthritis Care & Research | June 16, 2017 | Volume: 69 | Issue: 8 | Pages: 1111-1124

10.1002/acr.23274 | PMID 28620917 Get It

Objective This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence‐based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) including ankylosing spondylitis and psoriatic arthritis, juvenile idiopathic arthritis (JIA), or systemic lupus erythematosus (SLE) undergoing elective total hip (THA) or total knee arthroplasty (TKA). Methods A panel of rheumatologists, orthopedic surgeons specializing in hip and knee arthroplasty, and methodologists was convened to construct the key clinical questions to be answered in the guideline. A multi‐step systematic literature review was then conducted, from which evidence was synthesized for continuing versus withholding antirheumatic drug therapy and for optimal glucocorticoid management in the perioperative period. A Patient Panel was convened to determine patient values and preferences, and the Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of evidence and the strength of recommendations, using a group consensus process through a convened Voting Panel of rheumatologists and orthopedic surgeons. The strength of the recommendation reflects the degree of certainty that benefits outweigh harms of the intervention, or vice versa, considering the quality of available evidence and the variability in patient values and preferences. Results The guideline addresses the perioperative use of antirheumatic drug therapy including traditional disease‐modifying antirheumatic drugs, biologic agents, tofacitinib, and glucocorticoids in adults with RA, SpA, JIA, or SLE who are undergoing elective THA or TKA. It provides recommendations regarding when to continue, when to withhold, and when to restart these medications, and the optimal perioperative dosing of glucocorticoids. The guideline includes 7 recommendations, all of which are conditional and based on low‐ or moderate‐quality evidence. Conclusion This guideline should help decision‐making by clinicians and patients regarding perioperative antirheumatic medication management at the time of elective THA or TKA. These conditional recommendations reflect the paucity of high‐quality direct randomized controlled trial data.
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Springer, Bryan D. , Dasa, Vinod , George, Michael , Gewurz‐Singer, Ora, Giles, Jon T. , Johnson, Beverly , Mandl, Lisa A. , Mont, Michael A. , Sculco, Peter K. , Sporer, Scott M. , Stryker, Louis S., Turgunbaev, Marat, Brause, Barry D. , Gililland, Jeremy M. , Goodman, Mark A. , Hurley-Rosenblatt, Arlene, Kirou, Kyriakos A. , Losina, Elena , MacKenzie, Ronald, Russell, Linda , Sah, Alexander P. , Miller, Amy S., Singh, Jasvinder A. , Yates, Adolph J. , Losina, Elena , George, Michael , Losina, Elena , Singh, Jasvinder A , Goodman, Susan M. , Guyatt, Gordon , Abdel, Matthew P. , Lee, Steve C. , Chen, Antonia F. , Michaud, Kaleb D. , Mikuls, Ted R. , Losina, Elena , Giles, Jon T , Kirou, Kyriakos A

Arthritis & Rheumatology | June 16, 2017 | Volume: 69 | Issue: 8 | Pages: 1538-1551

10.1002/art.40149 | PMID 28620948 Get It

ObjectiveThis collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence‐based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) including ankylosing spondylitis and psoriatic arthritis, juvenile idiopathic arthritis (JIA), or systemic lupus erythematosus (SLE) undergoing elective total hip (THA) or total knee arthroplasty (TKA).MethodsA panel of rheumatologists, orthopedic surgeons specializing in hip and knee arthroplasty, and methodologists was convened to construct the key clinical questions to be answered in the guideline. A multi‐step systematic literature review was then conducted, from which evidence was synthesized for continuing versus withholding antirheumatic drug therapy and for optimal glucocorticoid management in the perioperative period. A Patient Panel was convened to determine patient values and preferences, and the Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of evidence and the strength of recommendations, using a group consensus process through a convened Voting Panel of rheumatologists and orthopedic surgeons. The strength of the recommendation reflects the degree of certainty that benefits outweigh harms of the intervention, or vice versa, considering the quality of available evidence and the variability in patient values and preferences.ResultsThe guideline addresses the perioperative use of antirheumatic drug therapy including traditional disease‐modifying antirheumatic drugs, biologic agents, tofacitinib, and glucocorticoids in adults with RA, SpA, JIA, or SLE who are undergoing elective THA or TKA. It provides recommendations regarding when to continue, when to withhold, and when to restart these medications, and the optimal perioperative dosing of glucocorticoids. The guideline includes 7 recommendations, all of which are conditional and based on low‐ or moderate‐quality evidence.ConclusionThis guideline should help decision‐making by clinicians and patients regarding perioperative antirheumatic medication management at the time of elective THA or TKA. These conditional recommendations reflect the paucity of high‐quality direct randomized controlled trial data.
Mitochondrial Integrity and Function in the Progression of Early Pressure Overload–Induced Left Ventricular Remodeling
Chaanine, Antoine H. , Bergen, Robert H., Klaus, Katherine A. , Guenzel, Adam J. , Hajjar, Roger J. , Redfield, Margaret M. , Klaus, Katherine, Nair, K. Sreekumaran

Journal of the American Heart Association | June 16, 2017 | Volume: 6 | Issue: 6 | Pages: No page available

10.1161/jaha.117.005869 | PMID 28619984 Get It

Background Following pressure overload, compensatory concentric left ventricular remodeling ( CR ) variably transitions to eccentric remodeling ( ER ) and systolic dysfunction. Mechanisms responsible for this transition are incompletely understood. Here we leverage phenotypic variability in pressure overload–induced cardiac remodeling to test the hypothesis that altered mitochondrial homeostasis and calcium handling occur early in the transition from CR to ER , before overt systolic dysfunction. Methods and Results Sprague Dawley rats were subjected to ascending aortic banding, (n=68) or sham procedure (n=5). At 3 weeks post–ascending aortic banding, all rats showed CR (left ventricular volumes < sham). At 8 weeks post–ascending aortic banding, ejection fraction was increased or preserved but 3 geometric phenotypes were evident despite similar pressure overload severity: persistent CR , mild ER , and moderate ER with left ventricular volumes lower than, similar to, and higher than sham, respectively. Relative to sham, CR and mild ER phenotypes displayed increased phospholamban, S16 phosphorylation, reduced sodium‐calcium exchanger expression, and increased mitochondrial biogenesis/content and normal oxidative capacity, whereas moderate ER phenotype displayed decreased p‐phospholamban, S16, increased sodium‐calcium exchanger expression, similar degree of mitochondrial biogenesis/content, and impaired oxidative capacity with unique activation of mitochondrial autophagy and apoptosis markers ( BNIP 3 and Bax/Bcl‐2). Conclusions After pressure overload, mitochondrial biogenesis and function and calcium handling are enhanced in compensatory CR . The transition to mild ER is associated with decrease in mitochondrial biogenesis and content; however, the progression to moderate ER is associated with enhanced mitochondrial autophagy/apoptosis and impaired mitochondrial function and calcium handling, which precede the onset of overt systolic dysfunction.
Dietary restriction but not angiotensin II type 1 receptor blockade improves DNA damage-related vasodilator dysfunction in rapidly agingErcc1Δ/−mice
Wu, Haiyan , Thiel, Bibi S. van, Bautista‐Niño, Paula K. , Reiling, Erwin, Durik, Matej , Leijten, Frank, Ridwan, Yanto, Brandt, Renata M. C. , Steeg, Harry van , Vermeij, Wilbert P. , Essers, Jeroen , Pluijm, Ingrid van der , Roks, Anton J.M. , Dollé, Martijn E.T. , Hoeijmakers, Jan H.J. , Danser, A.H. Jan

Clinical Science | June 16, 2017 | Volume: 131 | Issue: 15 | Pages: 1941-1953

10.1042/cs20170026 | PMID 28620011 Get It

DNA damage is an important contributor to endothelial dysfunction and age-related vascular disease. Recently, we demonstrated in a DNA repair-deficient, prematurely aging mouse model (Ercc1Δ/− mice) that dietary restriction (DR) strongly increases life- and health span, including ameliorating endothelial dysfunction, by preserving genomic integrity. In this mouse mutant displaying prominent accelerated, age-dependent endothelial dysfunction we investigated the signaling pathways involved in improved endothelium-mediated vasodilation by DR, and explore the potential role of the renin-angiotensin system (RAS). Ercc1Δ/− mice showed increased blood pressure and decreased aortic relaxations to acetylcholine (ACh) in organ bath experiments. Nitric oxide (NO) signaling and phospho-Ser1177-eNOS were compromised in Ercc1Δ/−. DR improved relaxations by increasing prostaglandin-mediated responses. Increase of cyclo-oxygenase 2 and decrease of phosphodiesterase 4B were identified as potential mechanisms. DR also prevented loss of NO signaling in vascular smooth muscle cells and normalized angiotensin II (Ang II) vasoconstrictions, which were increased in Ercc1Δ/− mice. Ercc1Δ/− mutants showed a loss of Ang II type 2 receptor-mediated counter-regulation of Ang II type 1 receptor-induced vasoconstrictions. Chronic losartan treatment effectively decreased blood pressure, but did not improve endothelium-dependent relaxations. This result might relate to the aging-associated loss of treatment efficacy of RAS blockade with respect to endothelial function improvement. In summary, DR effectively prevents endothelium-dependent vasodilator dysfunction by augmenting prostaglandin-mediated responses, whereas chronic Ang II type 1 receptor blockade is ineffective.
Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas
Hardell, Elin, Josefson, Sofia, Ghaderi, Mehran , Skeie-Jensen, Tone, Westbom-Fremer, Sofia , Cheek, Elizabeth, Bell, Debra, Selling, Jonas, Schoolmeester, John K., Måsbäck, Anna , Davidson, Ben , Carlson, Joseph W. , Carlson, Joseph W

American Journal of Surgical Pathology | June 15, 2017 | Volume: 41 | Issue: 9 | Pages: 1231-1237

10.1097/pas.0000000000000894 | PMID 28622181 Get It

Undifferentiated uterine sarcomas (UUS) are a heterogenous group of high-grade mesenchymal tumors. Although these tumors are highly aggressive, a subset of patients may experience long-term survival. These tumors have previously been divided morphologically into uniform and pleomorphic types. A previous study demonstrated that a mitotic index cutoff of 25 mitoses/10 high-power fields (corresponding to 11.16 mitotic figures/mm2) could successfully divide tumors into 2 prognostic groups with significantly different overall survival. The goals of the current study were to (1) validate this mitotic index cutoff in an independent, multicenter cohort and (2) explore the prognostic value of the mitotic index groups in relation to other clinicopathologic variables. Cases were included from 3 independent institutions: The Norwegian Radium Hospital, The Mayo Clinic, and Skåne University Hospital. A total of 40 tumors were included after central review. All cases were negative for the YWHAE-FAM22A/B and JAZF1-JJAZ1 translocations. Survival data were available on all patients. In this study, one-third of patients with UUS survived beyond 5 years. The crude (unadjusted) Cox Proportional Hazards model revealed a number of parameters that significantly impacted overall survival, including mitotic index group, patient age, stage, and the presence of tumor necrosis. Classification into the uniform and pleomorphic types was not prognostic. Combining these parameters into an adjusted model revealed that only the mitotic index group and stage were prognostic. On the basis of these findings, it is proposed that UUS be subdivided into “mitogenic” and “not otherwise specified” types.
Paucicellular Fibrointimal Proliferation Characterizes Pediatric Pulmonary Vein Stenosis
Kovach, Alexandra E. , Magcalas, Philip M., Ireland, Christina M. , McEnany, Kerry, Oliveira, André M. , Baird, Christopher W. , Vargas, Sara O. , Kieran, Mark W. , Jenkins, Kathy J. , Kovach, Alexandra E

American Journal of Surgical Pathology | June 15, 2017 | Volume: 41 | Issue: 9 | Pages: 1198-1204

10.1097/pas.0000000000000892 | PMID 28622179 Get It

Pulmonary vein stenosis (PVS) is a luminal narrowing of extrapulmonary pulmonary veins. In pediatric patients, it arises following repair of congenital heart disease, particularly anomalous pulmonary venous return; in lung disease, especially prematurity; and rarely in isolation. The etiology is unknown and the course often fatal without lung transplantation. We hypothesized that systematic clinicopathologic review of pediatric PVS could provide further pathogenic insight. We included patients who underwent first resection of pulmonary venous tissue for symptomatic PVS at our pediatric referral center from 1995 to 2014. Clinical records and hematoxylin and eosin slides were reviewed. Subsets were immunostained for smooth muscle actin, Ki-67, β-catenin, estrogen receptor, and other markers and analyzed forUSP6gene rearrangement. A total of 97 patients (57% male; median age: 6 mo) were identified. Overall, 59 (61%) had prior congenital heart disease repair, 35 involving pulmonary vein manipulation. Samples included 213 separate anatomic sites (median: 2/patient). Histologically, all showed sparsely cellular intimal expansion composed of haphazardly arranged fibroblasts with slender nuclei in myxoid matrix. This tissue merged with underlying collagen. Most samples had a variably continuous sheath of cardiomyocytes. Ancillary tests supported a reactive fibroblastic proliferation; in particular, fibroblasts showed cytoplasmic β-catenin localization, no estrogen receptor expression, and noUSP6rearrangement. At last follow-up (mean: 2.3 y), 46% of patients had died of disease. Pediatric PVS uniformly consists of a paucicellular fibrointimal proliferation, irrespective of clinical scenario. It may be best conceived of as a form of reactive hyperplasia. As with other forms of vascular remodeling, trauma (iatrogenic or occult) is likely an inciting factor. A comprehensive understanding of the surgical pathology of PVS may further inform therapeutic strategies in this lethal disease.